Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT01908504
Eligibility Criteria:
Inclusion Criteria:
* Pathologically (histologically or cytologically) proven diagnosis of carcinoma
* Patients with local or regional nodal disease are eligible.
* Zubrod Performance Status 0, 1, or 2.
* Age ≥ 18
* Negative serum pregnancy test for women of child bearing potential
* Patient must sign study-specific informed consent prior to study entry.
Exclusion Criteria:
* No gross disease visible on imaging at the start of radiotherapy
* Contraindication to PET
* Complete response by PET achieved with pre-radiation therapy treatment (surgery or chemotherapy)
* Breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT01908504
Study Brief:
Protocol Section:
NCT01908504